Tyrosine kinase inhibitor levels matter in treating chronic GVHD

Lotte van der Wagen, Julie Janssen, Reinier Raijmakers, Eefke Petersen, Moniek de Witte, Niels de Jong, Mar Bellido, Ellen Meijer, Brigitte Bär, Jaap Jan Boelens, Alwin Huitema, J. rgen Kuball

Research output: Contribution to journalLetterAcademicpeer-review


We observed a possible concentration effect relationship for nilotinib on resolution of chronic Graft versus Host disease.These data suggest therapeutic drug monitoring might be useful for patients receiving tyrosine kinase inhibitors for chronic GVHD.
Original languageEnglish
Pages (from-to)1141-1144
Number of pages4
JournalBone Marrow Transplantation
Issue number7
Publication statusPublished - 1 Jul 2019

Cite this